Prosecution Insights
Prosecution Insights
Technology area: Computing & Software
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Ascletis Bioscience Co. Ltd. maintains a company patent portfolio within the Computing & Software technology area. The data shows 1 pending office action currently in progress. This activity is limited to a lone distinct examiner and a lone distinct art unit, suggesting a very targeted approach to intellectual property in the software space. This concentration means that the company's current prosecution success is tied to a specific technical review channel within the patent office's Computing & Software division.
STCLAIR, ANDREW D is the busiest examiner for this portfolio, with 1 busiest examiner pending office action. This action constitutes the full extent of the company's pending office actions. For a patent practitioner, this indicates that the prosecution strategy does not currently benefit from examiner or art unit diversity. The outcome of the 1 pending office action will be the primary determinant of the portfolio's growth in the near term, as there are no other active matters to offset potential rejections.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STCLAIR, ANDREW D | 1 | 60.2% | +25.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18056836 | GLP-1R MODULATING COMPOUNDS | STCLAIR, ANDREW D | 383d overdue |
| Art Unit | Apps |
|---|---|
| 2178 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18056836 | GLP-1R MODULATING COMPOUNDS | STCLAIR, ANDREW D | 2178 | §102 | Non-Final OA | 383d overdue | Pending | Nov 18, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial